• Corpus ID: 15051311

Multiple Risk Factor Intervention Trial * Brown and Goldstein ' s research on low-density lipoprotein ( LDL ) receptors * Coronary Primary Prevention Trial * Helsinki Heart Study The

@inproceedings{Larosa2005MultipleRF,
  title={Multiple Risk Factor Intervention Trial * Brown and Goldstein ' s research on low-density lipoprotein ( LDL ) receptors * Coronary Primary Prevention Trial * Helsinki Heart Study The},
  author={Claudio Larosa and Donald B. Hunninghake and David Bush and H. M. Criqui and S Getz and Michelle A. Gotto and M. Grundy and Louis Rakita and Rose Marie Robertson and Scott M. Grundy and Peter W. F. Wilson and T B Clarkson and William W. Hay},
  year={2005},
  url={https://api.semanticscholar.org/CorpusID:15051311}
}
This statement reviews the epidemiologic, laboratory, and clinical studies that address questions most frequently asked about cholesterol and intends to remove doubts about the direct link between cholesterol and CHD.
circ.ahajournals.org

Figures and Tables from this paper

125 References

High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.

The results suggest a synergistic interaction, in which cholestyramine treatment reduced CHD risk most substantially in men maintaining the highest HDL-C levels.

EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE Report from the Oslo Study Group of a Randomised Trial in Healthy Men

Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics.

Lipoproteins, cardiovascular disease, and death. The Framingham study.

Based on six years of follow-up evaluations of the Framingham, Mass, men and women aged 49 to 82 years, it was found that a low-density lipoprotein (LDL) cholesterol concentration was associated with…

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.

A Controlled Clinical Trial of a Diet High in Unsaturated Fat in Preventing Complications of Atherosclerosis

This report describes a clinical trial, with domiciled male veterans, designed to determine whether a diet which lowers serum cholesterol concentration can prevent overt complications of coronary…

Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study.

It is concluded that the use of the serum-cholesterol-lowering diet exerted a substantial preventive effect on CHD.

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.

The LRC-CPPT findings show that reducing total cholesterol by lowering LDL-C levels can diminish the incidence of CHD morbidity and mortality in men at high risk for CHD because of raised cholesterol levels.

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Results are in accord with two previous trials with different pharmacologic agents and indicate that modification of lipoprotein levels with gemfibrozil reduces the incidence of coronary heart disease in men with dyslipidemia.
...